Recent Advances on Familial Hypercholesterolemia in Children and Adolescents

Recent Advances on Familial Hypercholesterolemia in Children and Adolescents

Familial hypercholesterolemia is a common autosomal hereditary disorder characterized by elevated concentrations of low-density lipoprotein cholesterol and the development of premature atherosclerosis and cardiovascular disease. Early diagnosis, as well as prompt and aggressive treatment, are fundam...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Francesca Mainieri, Veronica Maria Tagi, Francesco Chiarelli
Formatua:	Artikulua
Hizkuntza:	English
Argitaratua:	MDPI AG 2022-04-01
Saila:	Biomedicines
Gaiak:	familial hypercholesterolemia dyslipidemia low-density lipoprotein cholesterol atherosclerotic cardiovascular disease atherosclerosis treatment
Sarrera elektronikoa:	https://www.mdpi.com/2227-9059/10/5/1043

Antzeko izenburuak

RUSSIAN GUIDELINES ON FAMILIAL HYPERCHOLESTEROLEMIA DIAGNOSIS AND TREATMENT
nork: article Editorial
Argitaratua: (2017-06-01)

Age- and sex-based heterogeneity in coronary artery plaque presence and burden in familial hypercholesterolemia: A multi-national study
nork: Khurram Nasir, et al.
Argitaratua: (2024-03-01)

Familial hypercholesterolemia in Chinese children and adolescents: a multicenter study
nork: Meng-Na Huang, et al.
Argitaratua: (2024-12-01)

VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE
nork: V. А. Korneva, et al.
Argitaratua: (2017-03-01)

Patient with homozygous familial hypercholesterolemia: difficult to treat. Case report
nork: Andrey V. Susekov, et al.
Argitaratua: (2020-01-01)

Familial Hypercholesterolemia in Children. The Current State of the Problem
nork: Dinara I. Sadykova, et al.
Argitaratua: (2023-07-01)

Long-Term Efficacy and Safety of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia: Real-World Clinical Experience
nork: Claudia Stefanutti, et al.
Argitaratua: (2022-11-01)

The Prevalence of Different Genotypic Forms of Familial Hypercholesterolemia in Relation to Race and Ethnicity
nork: Makhabbat Bekbossynova, et al.
Argitaratua: (2024-08-01)

Tafolecimab in Chinese patients with non-familial hypercholesterolemia (CREDIT-1): a 48-week randomized, double-blind, placebo-controlled phase 3 trialResearch in context
nork: Yong Huo, et al.
Argitaratua: (2023-12-01)

Analysis of risk factors for aortic stenosis in patients with familial hypercholesterolemia
nork: V. A. Korneva, et al.
Argitaratua: (2025-02-01)

Case report: Young onset stroke from familial hypercholesterolemia
nork: Rizaldy Taslim Pinzon, et al.
Argitaratua: (2024-03-01)

In-hospital and mid-term follow-up of low-density lipoprotein cholesterol and target-goal attainment among patients with acute cerebral infarction: a retrospective study
nork: Zhong Chen, et al.
Argitaratua: (2024-02-01)

Lipoprotein (a) levels in children with heterozygous familial hypercholesterolemia
nork: Liliya F. Galimova, et al.
Argitaratua: (2024-12-01)

Familial Hypercholesterolemia
nork: FENG Siqin, et al.
Argitaratua: (2023-01-01)

Familial hypercholesterolemia: current status of the problem, treatment, and prevention
nork: S. A. Bliznyuk, et al.
Argitaratua: (2020-11-01)

A Case Report of Homozygous Familial Hypercholesterolemia Liver Transplantation
nork: CHEN Peipei, et al.
Argitaratua: (2023-01-01)

Hyperlipidemia and Cardiovascular Risk in Children and Adolescents
nork: Francesca Mainieri, et al.
Argitaratua: (2023-03-01)

Disorders of lipid metabolism. Clinical Guidelines 2023
nork: M. V. Ezhov, et al.
Argitaratua: (2023-06-01)

Current Treatment Options in Homozygous Familial Hypercholesterolemia
nork: Meral Kayikcioglu, et al.
Argitaratua: (2022-12-01)

Efficacy and Safety of Ongericimab in Chinese Patients With Primary Hypercholesterolemia and Mixed Dyslipidemia
nork: Xiaozeng Wang, et al.
Argitaratua: (2024-06-01)

Familial Hypercholesterolemia and Lipoprotein(a): A Gordian Knot in Cardiovascular Prevention
nork: Amalia Despoina Koutsogianni, et al.
Argitaratua: (2022-11-01)

Diagnostic Characteristics of Familial Hypercholesterolemia in Children
nork: Dinara I. Sadykova, et al.
Argitaratua: (2020-06-01)

Distinguishing Lysosomal Acid Lipase Deficiency From Familial Hypercholesterolemia
nork: Sohum Sheth, BS, et al.
Argitaratua: (2023-10-01)

2024 Polish recommendations for the management of familial hypercholesterolemia in children and adolescents
nork: Małgorzata Myśliwiec, et al.
Argitaratua: (2024-11-01)

Phenotype of heterozygous familial hypercholesterolemia caused by deletion of <i>LDLR</i> gene exons 2-10: a case report
nork: A. M. Moiseeva, et al.
Argitaratua: (2024-12-01)

Novel LDLR Variant in Familial Hypercholesterolemia: NGS-Based Identification, In Silico Characterization, and Pharmacogenetic Insights
nork: Mohammad Athar, et al.
Argitaratua: (2023-07-01)

A strategy to increase identification of patients with Familial Hypercholesterolemia: Application of the Simon Broome lipid criteria in a large-scale retrospective analysis
nork: James K. Fleming, et al.
Argitaratua: (2025-03-01)

Analytical Validation of Familial Hypercholesterolemia Biomarkers in Dried Blood Spots
nork: Patrice K. Held, et al.
Argitaratua: (2022-02-01)

FAMILIAL HYPERCHOLESTEROLEMIA: DIAGNOSTIC ISSUES AND THERAPEUTIC POSSIBILITIES
nork: Vitalii K. Zafiraki, et al.
Argitaratua: (2019-03-01)

Evolving Concepts of the SCORE System: Subtracting Cholesterol from Risk Estimation: A Way for a Healthy Longevity?
nork: Francesco Natale, et al.
Argitaratua: (2024-05-01)

Familial Hypercholesterolemia in the Elderly: An Analysis of Clinical Profile and Atherosclerotic Cardiovascular Disease Burden from the Hellas-FH Registry
nork: Christina Antza, et al.
Argitaratua: (2024-01-01)

CENTRALISED SURVEY ON THE UNDERTREATMENT OF THE HYPERCHOLESTEROLEMIA IN RUSSIA (CEPHEUS)
nork: S. A. Boytsov, et al.
Argitaratua: (2013-08-01)

Lipoprotein(a) in children and adolescents with genetically confirmed familial hypercholesterolemia followed up at a specialized lipid clinic
nork: Anja K. Johansen, et al.
Argitaratua: (2024-09-01)

Analysis of the low density lipoprotein receptor gene (<i>LDLR</i>) mutation spectrum in Russian familial hypercholesterolemia
nork: V. B. Vasilyev, et al.
Argitaratua: (2022-06-01)

Familial Hypercholesterolemia: From Clinical Suspicion to Novel Treatments
nork: Saeid Mirzai, et al.
Argitaratua: (2023-11-01)

Long-term effectiveness and safety of lomitapide in patients with homozygous familial hypercholesterolemia: an observational case series
nork: Patrizia Suppressa, et al.
Argitaratua: (2024-10-01)

Familial Hypercholesterolemia: Do HDL Play a Role?
nork: Juan Pedro-Botet, et al.
Argitaratua: (2021-07-01)

Discordance Between Very Low‐Density Lipoprotein Cholesterol and Low‐Density Lipoprotein Cholesterol Increases Cardiovascular Disease Risk in a Geographically Defined Cohort
nork: Kristina E. Seehusen, et al.
Argitaratua: (2024-04-01)

The German CaRe high registry for familial hypercholesterolemia – Sex differences, treatment strategies, and target value attainment
nork: Winfried März, et al.
Argitaratua: (2023-09-01)

Efficacy of targeted screening for familial hypercholesterolemia in children and adults aged <44 years: retrospective, prospective observational study
nork: Elena Yu. Emelyanchik, et al.
Argitaratua: (2024-04-01)